Literature DB >> 23303856

Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.

Xiaojun Yu1, Tingting Du, Ning Song, Qing He, Yong Shen, Hong Jiang, Junxia Xie.   

Abstract

OBJECTIVE: The present study aimed to evaluate alterations in the levels of iron, divalent metal transporter 1 (DMT1) with the iron-responsive element (IRE), transferrin receptor 1 (TfR1), ferroportin 1 (FPN1), and iron regulatory protein 1 (IRP1) in the temporal cortex of human brains with Parkinson disease (PD).
METHODS: Iron content was measured using an ICP-MS 7500CE detector. IRP1, DMT1+IRE, TfR1, and FPN1 expressions were determined by Western blotting.
RESULTS: Iron content was significantly lower in the temporal cortex of patients with PD when compared with age-matched healthy controls. Unexpectedly, the levels of DMT1+IRE, TfR1, FPN1, and IRP1 were decreased in the temporal cortex in PD brains. No changes were observed in the temporal cortex of postmortem Alzheimer disease brains.
CONCLUSIONS: Iron deprivation and iron-related protein dysregulation suggest that a different iron regulatory mechanism may exist, and that iron redistribution may occur between the temporal cortex and the substantia nigra of patients with PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303856      PMCID: PMC3590051          DOI: 10.1212/WNL.0b013e31827f0ebb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; John F Pearson; Sina Rüeger; Toni L Pitcher; Leslie Livingston; Charlotte Graham; Ross Keenan; Ajit Shankaranarayanan; David C Alsop; John C Dalrymple-Alford; Tim J Anderson
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

Review 2.  Iron regulatory proteins: from molecular mechanisms to drug development.

Authors:  Stefania Recalcati; Giorgio Minotti; Gaetano Cairo
Journal:  Antioxid Redox Signal       Date:  2010-11-15       Impact factor: 8.401

Review 3.  Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.

Authors:  Or Kakhlon; William Breuer; Arnold Munnich; Z Ioav Cabantchik
Journal:  Can J Physiol Pharmacol       Date:  2010-03       Impact factor: 2.273

4.  Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.

Authors:  Baptiste A Faucheux; Marie-Elise Martin; Carole Beaumont; Stéphane Hunot; Jean-Jacques Hauw; Yves Agid; Etienne C Hirsch
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

5.  Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.

Authors:  E Sofic; W Paulus; K Jellinger; P Riederer; M B Youdim
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

6.  Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.

Authors:  Hong Jiang; Ning Song; Huamin Xu; Shuzhen Zhang; Jun Wang; Junxia Xie
Journal:  Cell Res       Date:  2010-02-02       Impact factor: 25.617

7.  Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.

Authors:  Jun Wang; Hong Jiang; Jun-Xia Xie
Journal:  Eur J Neurosci       Date:  2007-05       Impact factor: 3.386

8.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

9.  Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.

Authors:  Julio Salazar; Natalia Mena; Stephane Hunot; Annick Prigent; Daniel Alvarez-Fischer; Miguel Arredondo; Charles Duyckaerts; Veronique Sazdovitch; Lin Zhao; Laura M Garrick; Marco T Nuñez; Michael D Garrick; Rita Raisman-Vozari; Etienne C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

10.  The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers
Journal:  Cell Tissue Bank       Date:  2008-03-18       Impact factor: 1.522

  10 in total
  21 in total

Review 1.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

2.  Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.

Authors:  Altair Brito Dos Santos; Marcos A Bezerra; Marcelo E Rocha; George E Barreto; Kristi A Kohlmeier
Journal:  J Neural Transm (Vienna)       Date:  2019-07-11       Impact factor: 3.575

3.  Short communication: high cellular iron levels are associated with increased HIV infection and replication.

Authors:  Hsiang-Chun Chang; Marina Bayeva; Babafemi Taiwo; Frank J Palella; Thomas J Hope; Hossein Ardehali
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-07       Impact factor: 2.205

Review 4.  New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.

Authors:  Na Zhang; Xiaoqi Yu; Junxia Xie; Huamin Xu
Journal:  Mol Neurobiol       Date:  2021-01-28       Impact factor: 5.590

5.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

6.  Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Christopher Gatenby; Sally Friend; Kenneth R Maravilla; Shu-Ching Hu; Kevin C Cain; Pinky Agarwal; Yoshimi Anzai
Journal:  J Neurol Sci       Date:  2017-04-23       Impact factor: 3.181

Review 7.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

8.  Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.

Authors:  Pengfei Cheng; Jia Yu; Wen Huang; Shunjie Bai; Xiaofeng Zhu; Zhigang Qi; Weihua Shao; Peng Xie
Journal:  Neurol Sci       Date:  2015-08-12       Impact factor: 3.307

9.  Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease.

Authors:  Leilei Chen; Chong Li; Junxia Xie
Journal:  Neurosci Bull       Date:  2020-09-22       Impact factor: 5.203

10.  Off-resonance saturation as an MRI method to quantify mineral- iron in the post-mortem brain.

Authors:  Lucia Bossoni; Ingrid Hegeman-Kleinn; Sjoerd G van Duinen; Marjolein Bulk; Lena H P Vroegindeweij; Janneke G Langendonk; Lydiane Hirschler; Andrew Webb; Louise van der Weerd
Journal:  Magn Reson Med       Date:  2021-10-15       Impact factor: 3.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.